From trials to statistical insights: Bortezomib's story in childhood T‐cell lymphoid malignancies

Bibliographic Details
Main Author:	Shyam Srinivasan
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

New insights into the Bortezomib‐induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model
by: Maria Anele Romeo, et al.
Published: (2024)

Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta‐Analysis
by: Lucio N. Gordan, et al.
Published: (2025)

Mortality associated to hematological malignancies across pandemic waves in 2020: A nationwide analysis of multiple causes of death in Italy
by: Enrico Grande, et al.
Published: (2024)

Bruton tyrosine kinase inhibitor monotherapy in B‐cell lymphoma and risk of infection: A systematic review and meta‐analysis of randomized controlled trials
by: Mohammed Zuber, et al.
Published: (2024)

739 | ADDRESSING HYPERCALCEMIA IN ADULT T‐CELL LEUKEMIA/LYMPHOMA
by: M. Srinivasan, et al.
Published: (2025)

Outcomes after treating advanced mantle cell lymphoma in a low‐income group at a Latin American center: The role of outpatient hematopoietic stem cell transplantation
by: José Carlos Jaime‐Pérez, et al.
Published: (2024)

Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan
by: Kenji Ishitsuka, et al.
Published: (2024)

Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients
by: Kaitlin Annunzio, et al.
Published: (2024)

Real‐world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL‐CLLEAR study
by: Anna Panovská, et al.
Published: (2024)

Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus‐associated mantle cell lymphoma
by: Jiangfang Feng, et al.
Published: (2024)

ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia
by: Zong‐Yan Shi, et al.
Published: (2024)

Metabolic pathway‐based subtyping reveals distinct microenvironmental states associated with diffuse large B‐cell lymphoma outcomes
by: Xiaohui Wang, et al.
Published: (2024)

Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario
by: Antonio Pinto, et al.
Published: (2024)

Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
by: Mariarita Sciumè, et al.
Published: (2024)

The RAS‐signaling‐pathway‐mutation‐related prognosis in B‐cell acute lymphoblastic leukemia: A report from South China children's leukemia group
by: Xinyu Li, et al.
Published: (2024)

Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
by: Taku Kikuchi, et al.
Published: (2024)

Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group
by: Evgenia Verrou, et al.
Published: (2024)

Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy
by: Hidehiro Itonaga, et al.
Published: (2024)

Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study
by: Dong Liang, et al.
Published: (2025)

Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study
by: Pallawi Torka, et al.
Published: (2025)

NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort
by: Calogero Vetro, et al.
Published: (2026)

Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate‐1‐Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI)
by: Paola Guglielmelli, et al.
Published: (2026)

CAR T‐Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real‐World Experiences From a Single Center on the Use of Radiotherapy
by: J.T. Jutzi, et al.
Published: (2025)

Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[ 18 F]FDG PET/CT in Advanced Mantle Cell Lymphoma
by: Domenico Albano, et al.
Published: (2024)

Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience
by: Robin Noel, et al.
Published: (2025)

Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor‐Naïve Patients With Myelofibrosis From the Multicenter, Open‐Label, Phase 2 Study (REFINE)
by: Francesco Passamonti, et al.
Published: (2026)

Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real‐Life Multicenter Experience. Results From the REDOT_MCL Study
by: Francesca Maria Quaglia, et al.
Published: (2026)

Re: Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience
by: Theodoros P. Vassilakopoulos, et al.
Published: (2025)

Correction to “Defining and Addressing the Current Unmet Medical Needs for the Frontline Treatment of Advanced Stage Aggressive Large B‐Cell Lymphoma: A Perspective From an Ad Hoc Panel of Italian Experts”
Published: (2025)

Comparative Effectiveness of R‐miniCOMP Versus R‐miniCHOP in Older Non‐Fit Patients With Diffuse Large B‐Cell Lymphoma: Insights From a “Fondazione Italiana Linfomi” Cohort Study
by: Alberto Bavieri, et al.
Published: (2025)

Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis
by: Maria Livia Del Giudice, et al.
Published: (2024)

In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T‐Cell Neoplasms
by: Marie Therese Manipadam, et al.
Published: (2024)

Clonal dynamics of Richter transformation in chronic lymphocytic leukemia
by: Hanyin Wang, et al.
Published: (2024)

Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients
by: A. Zduniak, et al.
Published: (2024)

The role of baseline 2‐[ 18 F]‐FDG‐PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis
by: Domenico Albano, et al.
Published: (2024)

Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B‐Cell Lymphoma
by: Meirav Kedmi, et al.
Published: (2024)

Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT‐Lymphoma) of the Intestine: A Single Center Analysis
by: Oskar Steinbrecher, et al.
Published: (2024)

How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia
by: Nayla Mouawad, et al.
Published: (2024)

Real‐life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience
by: Vittorio Ruggero Zilioli, et al.
Published: (2024)

FLT3‐ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia
by: María Turos‐Cabal, et al.
Published: (2024)

Similar Items

Similar Items